title: ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
authors.affiliation: AP-HP, Hôpital Bichat / Univ Paris Diderot, Sorbonne Paris-Cité / INSERM U-698, Paris, France. gabriel.steg@bch.aphp.fr
authors.forename: Ph Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Stefan K
authors.initials: SK
authors.lastname: James
authors.forename: Dan
authors.initials: D
authors.lastname: Atar
authors.forename: Luigi P
authors.initials: LP
authors.lastname: Badano
authors.forename: Carina
authors.initials: C
authors.lastname: Blömstrom-Lundqvist
authors.forename: Michael A
authors.initials: MA
authors.lastname: Borger
authors.forename: Carlo
authors.initials: C
authors.lastname: Di Mario
authors.forename: Kenneth
authors.initials: K
authors.lastname: Dickstein
authors.forename: Gregory
authors.initials: G
authors.lastname: Ducrocq
authors.forename: Francisco
authors.initials: F
authors.lastname: Fernandez-Aviles
authors.forename: Anthony H
authors.initials: AH
authors.lastname: Gershlick
authors.forename: Pantaleo
authors.initials: P
authors.lastname: Giannuzzi
authors.forename: Sigrun
authors.initials: S
authors.lastname: Halvorsen
authors.forename: Kurt
authors.initials: K
authors.lastname: Huber
authors.forename: Peter
authors.initials: P
authors.lastname: Juni
authors.forename: Adnan
authors.initials: A
authors.lastname: Kastrati
authors.forename: Juhani
authors.initials: J
authors.lastname: Knuuti
authors.forename: Mattie J
authors.initials: MJ
authors.lastname: Lenzen
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Mahaffey
authors.forename: Marco
authors.initials: M
authors.lastname: Valgimigli
authors.forename: Arnoud
authors.initials: A
authors.lastname: van 't Hof
authors.forename: Petr
authors.initials: P
authors.lastname: Widimsky
authors.forename: Doron
authors.initials: D
authors.lastname: Zahger
mesh_terms: D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001007:Anxiety / Q000517:prevention & control; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000628:therapy; D035843:Biomedical Research / Q000639:trends; D057791:Cardiac Imaging Techniques / Q000379:methods; D009202:Cardiomyopathies / Q000209:etiology / Q000628:therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use; D001026:Coronary Artery Bypass / Q000379:methods; D004417:Dyspnea / Q000517:prevention & control; D004562:Electrocardiography; D004632:Emergency Medical Services / Q000458:organization & administration; D004638:Emergency Treatment / Q000379:methods; D005081:Exercise Therapy / Q000379:methods; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005544:Forecasting; D058006:General Practice / Q000458:organization & administration; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006439:Hemodynamics / Q000502:physiology; D006760:Hospitalization; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000628:therapy; D008134:Long-Term Care; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000379:methods; D058687:Out-of-Hospital Cardiac Arrest / Q000175:diagnosis / Q000628:therapy; D010146:Pain / Q000517:prevention & control; D062645:Percutaneous Coronary Intervention / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D040242:Risk Reduction Behavior; D061665:Time-to-Treatment
chemical_list: D000933:Antifibrinolytic Agents; D002316:Cardiotonic Agents; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors